choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Aegerion Pharmaceuticals IPO

Aegerion Pharmaceuticals IPO Newsletter
  • Former Amryt Pharma Leadership Team join Poolbeg 09 Nov 2023 11:35 GMT

    … the EMEA team at Aegerion Pharmaceuticals and was the Corporate … acquisition of Aegerion Pharmaceuticals in 2019 and Chiasma Pharmaceuticals in 2021. … -founded in 2015 and IPO'd on AIM … .com About Poolbeg Pharma Poolbeg Pharma specialises in the …

  • Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 26 Jun 2020 12:22 GMT

    … by biotech firms. IPO research firm Renaissance Capital … prescribed medicines. —Biohaven Pharmaceutical (NASDAQ: BHVN) drug … THIS WEEK IN BIOTECH IPOS —Cambridge, MA-based … Cambridge, MA, operates as Aegerion Pharmaceuticals. —Compass Therapeutics, which …

  • Cathal Friel chaired EGT to float on AIM in London 18 Mar 2024 21:27 GMT

    … (AIM) in London. The initial public offering would be the fifth led … founder of hVIVO and Poolbeg Pharma owns 7.1% and … an IPO in 2016, Amyrt Pharma acquired distressed assets of Birken, Aegerion … namely Cove Energy plc, Amryt Pharma plc and hVIVO plc. We …

  • Movers & Shakers: New CEOs at 7 Biopharma Companies 23 Sep 2022 20:05 GMT

    … at Sanofi, GlaxoSmithKline and Dupont Pharmaceuticals. Current CEO Andrew Kucharchuk will … served as global president of Aegerion Pharmaceuticals Inc. and vice president and … led the company through its initial public offering. Richman will continue to serve …

  • Silence Therapeutics Appoints Mark Rothera as President and Chief Executive Officer 14 Sep 2020 11:00 GMT

    … leadership, Orchard completed an initial public offering of American Depositary Shares on … served as Global President of Aegerion Pharmaceuticals Inc. and Vice President … and collaborations with AstraZeneca, Mallinckrodt Pharmaceuticals and Takeda. For more …

  • Akcea Expands Leadership Team in Preparation for First Commercial Launch 05 Sep 2017 11:00 GMT

    … officer immediately following PureTech’s initial public offering. Previously, Mr. MacLean … Pharmaceuticals, Inc., Alcon/Novartis Pharma AG and most recently Aegerion Pharmaceuticals, … trademark of Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals™ is a …

Satisfied with the content?

Continue to create your account.